SEC Form 4 · accession 0001923794-26-000004
Candel Therapeutics, Inc. · CADL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seshu Tyagarajan
Officer — Chief Technology Officer
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001841387
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2026 | S | 7,000 | $12.00 | D | 76,865 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/16/2026.